TE_17
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L1MEb_5end |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | C1orf159 |
Class | Chimeric |
Coding | Non-coding, Other |
Tumor-specific score | 0.86 |
Counts of samples | TCGA_tumor:109; TCGA_normal:4; GTEx:139 |
TSS | chr1(-):1103578 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_17.1 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1090876,1090983,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.2 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1082967,1082987,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.3 | C1orf159 | Chimeric | Other | MALRHLALLAGLLVGVASKSMENTAQLPECCVDVVGVNASCPGASLCGPGCYRRWNADGSASCVRCGNGTLPAYNGSECRSFAGPGAPFPMNRSSGTPGRPHPGAPRVAASLFLGTFFISSGLILSVAGFFYLKRSSKLPRACYRRNKAPALQPGEAAAMIPPPQSSDVGSAGKEDPPRQGRPPIPAPP* | chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.4 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1082967,1082987,1083915,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.5 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1082967,1082987,1083915,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1091374,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.6 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1082967,1082987,1083915,1084011,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.7 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1084066,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.8 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
teRNA_17.9 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091609,1091991,1092103,1103526,1103579 |
teRNA_17.10 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087577,1087597,1090353,1090428,1091472,1091565,1091991,1092103,1103526,1103579 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.